In this study, genetic polymorphisms, NQO1 C609T, GSTM1 positive/null, and GSTT1 positive/null, were examined with reference to cervical cancer risk in a population- based incident case- control study in Japanese. The...In this study, genetic polymorphisms, NQO1 C609T, GSTM1 positive/null, and GSTT1 positive/null, were examined with reference to cervical cancer risk in a population- based incident case- control study in Japanese. The cases comprised 131 cervical cancer patients: 87 cases with squamous cell carcinoma (SCC) and 44 with adenocarcinoma (ADC) or adenosquamous carcinoma (ADSC). Controls were sampled from 320 healthy women who underwent a health checkup. The cervical cancer risk was substantially elevated with smoking for all cases, SCC cases, and ADC/ADSC cases (OR = 4.50, 95% CI = 2.48- 8.17, P <0.001; OR = 5.68, 95% CI = 2.99- 10.78, P <0.001; and OR = 2.57, 95% CI = 1.09- 6.08, P = 0.032; respectively). The frequency of the NQO1 609TT genotype, reported to be associated with null enzyme activity, was higher in individuals with all cases and SCC than in the healthy controls (OR = 1.97, 95% CI = 1.06- 3.66, P = 0.032; and OR = 2.42, 95% CI = 1.21- 4.82, P = 0.012; respectively), but not in ADC/ADSC cases. Analysis of polymorphisms for GSTM1 and GSTT1 showed no significant differences between cervical cancer patients and controls. In stratification analysis, significant elevated risk of all cases and SCC was associated with the NQO1 609TT genotype among nonsmokers (OR = 2.15, 95% CI = 1.08- 4.30, P = 0.030; and OR = 2.83, 95% CI = 1.21- 6.31, P = 0.011; respectively), but not smokers. No gene- gene interaction was observed in our case subjects. This is the first report that the NQO1 gene might be important in relation to the risk of squamous cell carcinoma of the cervix.展开更多
文摘In this study, genetic polymorphisms, NQO1 C609T, GSTM1 positive/null, and GSTT1 positive/null, were examined with reference to cervical cancer risk in a population- based incident case- control study in Japanese. The cases comprised 131 cervical cancer patients: 87 cases with squamous cell carcinoma (SCC) and 44 with adenocarcinoma (ADC) or adenosquamous carcinoma (ADSC). Controls were sampled from 320 healthy women who underwent a health checkup. The cervical cancer risk was substantially elevated with smoking for all cases, SCC cases, and ADC/ADSC cases (OR = 4.50, 95% CI = 2.48- 8.17, P <0.001; OR = 5.68, 95% CI = 2.99- 10.78, P <0.001; and OR = 2.57, 95% CI = 1.09- 6.08, P = 0.032; respectively). The frequency of the NQO1 609TT genotype, reported to be associated with null enzyme activity, was higher in individuals with all cases and SCC than in the healthy controls (OR = 1.97, 95% CI = 1.06- 3.66, P = 0.032; and OR = 2.42, 95% CI = 1.21- 4.82, P = 0.012; respectively), but not in ADC/ADSC cases. Analysis of polymorphisms for GSTM1 and GSTT1 showed no significant differences between cervical cancer patients and controls. In stratification analysis, significant elevated risk of all cases and SCC was associated with the NQO1 609TT genotype among nonsmokers (OR = 2.15, 95% CI = 1.08- 4.30, P = 0.030; and OR = 2.83, 95% CI = 1.21- 6.31, P = 0.011; respectively), but not smokers. No gene- gene interaction was observed in our case subjects. This is the first report that the NQO1 gene might be important in relation to the risk of squamous cell carcinoma of the cervix.
